Novartis push to expand cancer arsenal gets trial win against Pfizer Bosulif Ruchika Sharma28 Aug 2020 9:30 AM ISTZurich: Novartis drug candidate asciminib notched a trial win against Pfizer's Bosulif, the Swiss drugmaker said on Wednesday, as it pushes to expand...
Pfizer, BioNTech coronavirus vaccine shows fewer side effects MD Bureau22 Aug 2020 10:00 AM ISTNew York: US-based Pfizer and German biotech firm BioNTech announced positive results for the Phase 1 trial of their second Covid-19 vaccine...
Pfizer teams up with Gilead to help manufacture Covid drug remdesivir Ruchika Sharma10 Aug 2020 12:38 PM ISTUS: Pfizer Inc (PFE.N) said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc...
Unichem Labs gets USFDA nod to Tolterodine Tartrate Tablet to treat overactive bladder Ruchika Sharma9 Aug 2020 10:00 AM ISTMumbai: Unichem Laboratories Limited has announced that it has received ANDA approval for its Tolterodine Tartrate Tablets, USP 1 mg and 2...
Pfizer, Moderna strike deals with Canada for supply of COVID-19 vaccines Ruchika Sharma7 Aug 2020 9:15 AM ISTOttawa: Canada has signed separate deals with Pfizer Inc and Moderna Inc to supply millions of doses of their experimental coronavirus vaccines,...
Pfizer-BioNTech potential COVID vaccine shows promise in second early trial Medical Dialogues Bureau1 Aug 2020 9:45 AM ISTNew York: German biotech BioNTech and U.S. drugmaker Pfizer Inc recently said data from an early-stage trial of their experimental coronavirus vaccine...
EU talks with Pfizer, Sanofi, JnJ on Potential COVID Vaccines Struggle To Reach Deal: Report Ruchika Sharma29 July 2020 9:30 AM ISTMilan: European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment...
Pfizer, BioNTech ink vaccine deal with US worth USD 2 billion Ruchika Sharma25 July 2020 9:15 AM ISTUnder the agreement, the US government has placed an initial order for 100 million doses to be delivered if regulatory approval is granted.
Pfizer, BioNTech coronavirus vaccine candidates get USFDA 'fast track' status Ruchika Sharma15 July 2020 9:30 AM ISTThe two candidates to win the designation, BNT162b1 and BNT162b2, are the most advanced of the at least four vaccines being assessed by the companies...
Pfizer, BioNTech COVID-19 vaccine expected to be ready for approval by 2020 end Ruchika Sharma12 July 2020 9:00 AM ISTIf it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the...
Pfizer, BioNTech early trial of COVID-19 vaccine shows promise Ruchika Sharma6 July 2020 9:30 AM ISTNew York: Pfizer Inc. and BioNTech SE have announced preliminary data from the most advanced of four investigational vaccine candidates from their...
Mylan Shareholders Overwhelmingly Approve Proposed merger with Upjohn Ruchika Sharma2 July 2020 9:00 AM ISTHertfordshire and Pittsburgh: Mylan N.V. has announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan...
